APMD
Apnimed, Inc. - Common Stock (APMD)
$81
About Apnimed, Inc. - Common Stock (APMD)
Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
Details
Daily high
$35.29
Daily low
$30.50
Price at open
$32.85
52 Week High
$35.29
52 Week Low
$16.00
Market cap
1.4B
Dividend yield
-
Volume
347,945
Avg. volume
626,057
P/E ratio
--
Apnimed, Inc. - Common Stock News
Details
Daily high
$35.29
Daily low
$30.50
Price at open
$32.85
52 Week High
$35.29
52 Week Low
$16.00
Market cap
1.4B
Dividend yield
-
Volume
347,945
Avg. volume
626,057
P/E ratio
--